Coronavirus membrane fusion mechanism offers as a potential target for antiviral development.
Identifieur interne : 000239 ( Main/Exploration ); précédent : 000238; suivant : 000240Coronavirus membrane fusion mechanism offers as a potential target for antiviral development.
Auteurs : Tiffany Tang [États-Unis] ; Miya Bidon [États-Unis] ; Javier A. Jaimes [États-Unis] ; Gary R. Whittaker [États-Unis] ; Susan Daniel [États-Unis]Source :
- Antiviral research [ 1872-9096 ] ; 2020.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has focused attention on the need to develop effective therapies against the causative agent, SARS-CoV-2, and also against other pathogenic coronaviruses (CoV) that have emerged in the past or might appear in future. Researchers are therefore focusing on steps in the CoV replication cycle that may be vulnerable to inhibition by broad-spectrum or specific antiviral agents. The conserved nature of the fusion domain and mechanism across the CoV family make it a valuable target to elucidate and develop pan-CoV therapeutics. In this article, we review the role of the CoV spike protein in mediating fusion of the viral and host cell membranes, summarizing the results of research on SARS-CoV, MERS-CoV, and recent peer-reviewed studies of SARS-CoV-2, and suggest that the fusion mechanism be investigated as a potential antiviral target. We also provide a supplemental file containing background information on the biology, epidemiology, and clinical features of all human-infecting coronaviruses, along with a phylogenetic tree of these coronaviruses.
DOI: 10.1016/j.antiviral.2020.104792
PubMed: 32272173
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000058
- to stream PubMed, to step Curation: 000058
- to stream PubMed, to step Checkpoint: 000247
- to stream Ncbi, to step Merge: 002733
- to stream Ncbi, to step Curation: 002733
- to stream Ncbi, to step Checkpoint: 002733
- to stream Main, to step Merge: 000242
- to stream Main, to step Curation: 000239
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coronavirus membrane fusion mechanism offers as a potential target for antiviral development.</title><author><name sortKey="Tang, Tiffany" sort="Tang, Tiffany" uniqKey="Tang T" first="Tiffany" last="Tang">Tiffany Tang</name><affiliation wicri:level="4"><nlm:affiliation>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Bidon, Miya" sort="Bidon, Miya" uniqKey="Bidon M" first="Miya" last="Bidon">Miya Bidon</name><affiliation wicri:level="4"><nlm:affiliation>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Jaimes, Javier A" sort="Jaimes, Javier A" uniqKey="Jaimes J" first="Javier A" last="Jaimes">Javier A. Jaimes</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, Cornell University, Ithaca, NY, 14853, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Whittaker, Gary R" sort="Whittaker, Gary R" uniqKey="Whittaker G" first="Gary R" last="Whittaker">Gary R. Whittaker</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, Cornell University, Ithaca, NY, 14853, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Daniel, Susan" sort="Daniel, Susan" uniqKey="Daniel S" first="Susan" last="Daniel">Susan Daniel</name><affiliation wicri:level="4"><nlm:affiliation>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853, USA. Electronic address: sd386@cornell.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32272173</idno><idno type="pmid">32272173</idno><idno type="doi">10.1016/j.antiviral.2020.104792</idno><idno type="wicri:Area/PubMed/Corpus">000058</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000058</idno><idno type="wicri:Area/PubMed/Curation">000058</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000058</idno><idno type="wicri:Area/PubMed/Checkpoint">000247</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000247</idno><idno type="wicri:Area/Ncbi/Merge">002733</idno><idno type="wicri:Area/Ncbi/Curation">002733</idno><idno type="wicri:Area/Ncbi/Checkpoint">002733</idno><idno type="wicri:Area/Main/Merge">000242</idno><idno type="wicri:Area/Main/Curation">000239</idno><idno type="wicri:Area/Main/Exploration">000239</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Coronavirus membrane fusion mechanism offers as a potential target for antiviral development.</title><author><name sortKey="Tang, Tiffany" sort="Tang, Tiffany" uniqKey="Tang T" first="Tiffany" last="Tang">Tiffany Tang</name><affiliation wicri:level="4"><nlm:affiliation>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Bidon, Miya" sort="Bidon, Miya" uniqKey="Bidon M" first="Miya" last="Bidon">Miya Bidon</name><affiliation wicri:level="4"><nlm:affiliation>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Jaimes, Javier A" sort="Jaimes, Javier A" uniqKey="Jaimes J" first="Javier A" last="Jaimes">Javier A. Jaimes</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, Cornell University, Ithaca, NY, 14853, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Whittaker, Gary R" sort="Whittaker, Gary R" uniqKey="Whittaker G" first="Gary R" last="Whittaker">Gary R. Whittaker</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, Cornell University, Ithaca, NY, 14853, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Daniel, Susan" sort="Daniel, Susan" uniqKey="Daniel S" first="Susan" last="Daniel">Susan Daniel</name><affiliation wicri:level="4"><nlm:affiliation>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853, USA. Electronic address: sd386@cornell.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853</wicri:regionArea><orgName type="university">Université Cornell</orgName><placeName><settlement type="city">Ithaca (New York)</settlement><region type="state">État de New York</region></placeName></affiliation></author></analytic><series><title level="j">Antiviral research</title><idno type="eISSN">1872-9096</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The coronavirus disease 2019 (COVID-19) pandemic has focused attention on the need to develop effective therapies against the causative agent, SARS-CoV-2, and also against other pathogenic coronaviruses (CoV) that have emerged in the past or might appear in future. Researchers are therefore focusing on steps in the CoV replication cycle that may be vulnerable to inhibition by broad-spectrum or specific antiviral agents. The conserved nature of the fusion domain and mechanism across the CoV family make it a valuable target to elucidate and develop pan-CoV therapeutics. In this article, we review the role of the CoV spike protein in mediating fusion of the viral and host cell membranes, summarizing the results of research on SARS-CoV, MERS-CoV, and recent peer-reviewed studies of SARS-CoV-2, and suggest that the fusion mechanism be investigated as a potential antiviral target. We also provide a supplemental file containing background information on the biology, epidemiology, and clinical features of all human-infecting coronaviruses, along with a phylogenetic tree of these coronaviruses.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region><settlement><li>Ithaca (New York)</li></settlement><orgName><li>Université Cornell</li></orgName></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Tang, Tiffany" sort="Tang, Tiffany" uniqKey="Tang T" first="Tiffany" last="Tang">Tiffany Tang</name></region><name sortKey="Bidon, Miya" sort="Bidon, Miya" uniqKey="Bidon M" first="Miya" last="Bidon">Miya Bidon</name><name sortKey="Daniel, Susan" sort="Daniel, Susan" uniqKey="Daniel S" first="Susan" last="Daniel">Susan Daniel</name><name sortKey="Jaimes, Javier A" sort="Jaimes, Javier A" uniqKey="Jaimes J" first="Javier A" last="Jaimes">Javier A. Jaimes</name><name sortKey="Whittaker, Gary R" sort="Whittaker, Gary R" uniqKey="Whittaker G" first="Gary R" last="Whittaker">Gary R. Whittaker</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000239 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000239 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32272173
|texte= Coronavirus membrane fusion mechanism offers as a potential target for antiviral development.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32272173" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |